New insights into the biological effects of anthrax toxins: Linking cellular to organismal responses

Microbes and Infection

Volumn 14, Issue 2, 2012, Pages 97-118

  Guichard, Annabel ^a   Nizet, Victor ^b,c   Bier, Ethan ^a  

^a SECTION OF CELL AND DEVELOPMENTAL BIOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anthrax; Edema factor (EF); Exocyst; Lethal factor (LF); Notch; Vascular endothelium cells (VEC)

Indexed keywords

ANTHRAX TOXIN; ANTIBIOTIC AGENT; CORTICOSTEROID; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EDEMA TOXIN; EXOCYST; G PROTEIN COUPLED RECEPTOR; HYPERTENSIVE FACTOR; LETHAL TOXIN; SYNDECAN 1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADRENAL GLAND; ANTHRAX; ANTIBIOTIC THERAPY; BACILLUS ANTHRACIS; BACTERIAL VIRULENCE; BLOOD VESSEL PERMEABILITY; BONE MARROW CELL; BRAIN; CELL INTERACTION; CELL JUNCTION; CELL MIGRATION; CELL TYPE; CHEMICAL STRUCTURE; COLLAPSE; CORTICOSTEROID THERAPY; HEART; HUMAN; IMMUNITY; IMMUNOCOMPETENT CELL; IN VIVO STUDY; INFLAMMATORY SHOCK; KIDNEY; MOLECULAR DYNAMICS; MURAL CELL; NONHUMAN; PRIORITY JOURNAL; SHOCK; SHORT SURVEY; SPLEEN; TRANSCYTOSIS; VASCULAR ENDOTHELIAL CELL;

ANIMALS; ANTHRAX; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; CARDIOVASCULAR SYSTEM; ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR JUNCTIONS; TRANSCYTOSIS; VIRULENCE FACTORS;

BACILLUS ANTHRACIS; BACTERIA (MICROORGANISMS);

EID: 84855906688     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2011.08.016     Document Type: Short Survey

References (190)

1. R. Koch (Ed.), Beitrage zur Biologie der Pflanzen, Zweiter Band, Zweites Heft, Breslau, 1876.
2. Pasteur L., Chamberland C., Roux E. Compte-rendu sommaire des expériences faites à Pouilly-le-Fort, près Melun, sur la vaccination charbonneuse. C. R. Acad. Sci. Paris 1881, 92:1393-1398.
3. Pasteur L., Chamberland C., Roux E. Summary report of the experiments conducted at Pouilly-le-Fort, near Melun, on anthrax vaccination. Yale J. Biol. Med. 2002, 75:59-62.
4. Fitzgerald J.G. Louis Pasteur - his contribution to anthrax, vaccination and the evolution of a principle of active immunization. Cal. State J. Med. 1923, 21:101-103.
5. Schwartz M. Dr. Jekyll and Mr. Hyde: a short history of anthrax. Mol. Aspects Med. 2009, 30:347-355.
6. Scorpio A., Blank T.E., Day W.A., Chabot D.J. Anthrax vaccines: Pasteur to the present. Cell. Mol. Life Sci. 2006, 63:2237-2248.
7. Le charbon et la vaccination charbonneuse d'après les travaux récents de M. Pasteur 1883, Bernard Tignol, Paris. C. Chamberland (Ed.).
8. Pasteur L., Joubert J. Charbon et septicémie. C. R. Acad. Sci. Paris 1877, 85:101-105.
9. Marmier L. Sur la toxine charbonneuse. Ann. Inst. Pasteur 1895, 9:533-574.
10. Bail O. Untersuchungen uber naturliche and kunstliche Milzbrandimmunitat. XI. Erster Bericht uber Milzbrandschutzimpfugen on Schafen. Centralbl. f. Bakteriol. Abt I, Orig. 1904, 37:270-280.
11. Cromartie W.J., Watson D.W., et al. Studies on infection with Bacillus anthracis; II. The immunological and tissue damaging properties of extracts prepared from lesions of B. anthracis infections. J. Infect. Dis. 1947, 80:14-27.
12. Bail O. Untersuchungen uber naturliche and kunstliche Milzbrandimmunitat. Zentrabl. Bakteriol. Parassiten. Infektionskr. I. rig. 1904, 36:262-272.
13. Gladstone G.P. Immunity to anthrax: protective antigen present in cell-free culture filtrates. Br. J. Exp. Pathol. 1946, 27:394-418.
14. Smith H. Discovery of the anthrax toxin: the beginning of studies of virulence determinants regulated invivo. Int. J. Med. Microbiol. 2002, 291:411-417.
15. Stanley J.L., Smith H. Purification of factor I and recognition of a third factor of the anthrax toxin. J. Gen. Microbiol. 1961, 26:49-63.
16. Abrami L., Reig N., van der Goot F.G. Anthrax toxin: the long andwinding road that leads to the kill. Trends Microbiol. 2005, 13:72-78.
17. Guidi-Rontani C., Weber-Levy M., Mock M., Cabiaux V. Translocation of Bacillus anthracis lethal and oedema factors across endosome membranes. Cell. Microbiol. 2000, 2:259-264.
18. Zornetta I., Brandi L., Janowiak B., Dal Molin F., Tonello F., Collier R.J., Montecucco C. Imaging the cell entry of the anthrax oedema and lethal toxins with fluorescent protein chimeras. Cell. Microbiol. 2010, 12:1435-1445.
19. Duesbery N.S., Webb C.P., Leppla S.H., Gordon V.M., Klimpel K.R., Copeland T.D., Ahn N.G., Oskarsson M.K., Fukasawa K., Paull K.D., Vande Woude G.F. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 1998, 280:734-737.
20. Park J.M., Greten F.R., Li Z.W., Karin M. Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 2002, 297:2048-2051.
21. Vitale G., Pellizzari R., Recchi C., Napolitani G., Mock M., Montecucco C. Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. Biochem. Biophys. Res. Commun. 1998, 248:706-711.
22. Tonello F., Montecucco C. The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity. Mol. Aspects Med. 2009, 30:431-438.
23. Bardwell A.J., Frankson E., Bardwell L. Selectivity of docking sites in MAPK kinases. J. Biol. Chem. 2009, 284:13165-13173.
24. Leppla S.H. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc. Natl. Acad. Sci. U.S.A. 1982, 79:3162-3166.
25. Tang W.J., Guo Q. The adenylyl cyclase activity of anthrax edema factor. Mol. Aspects Med. 2009, 30:423-430.
26. Dal Molin F., Tonello F., Ladant D., Zornetta I., Zamparo I., Di Benedetto G., Zaccolo M., Montecucco C. Cell entry and cAMP imaging of anthrax edema toxin. EMBO J. 2006, 25:5405-5413.
27. Dal Molin F., Zornetta I., Puhar A., Tonello F., Zaccolo M., Montecucco C. cAMP imaging of cells treated with pertussis toxin, cholera toxin, and anthrax edema toxin. Biochem. Biophys. Res. Commun. 2008, 376:429-433.
28. Turk B.E. Manipulation of host signalling pathways by anthrax toxins. Biochem. J. 2007, 402:405-417.
29. Young J.A., Collier R.J. Anthrax toxin: receptor binding, internalization, pore formation, and translocation. Annu. Rev. Biochem. 2007, 76:243-265.
30. Liu S., Schubert R.L., Bugge T.H., Leppla S.H. Anthrax toxin: structures, functions and tumour targeting. Expert Opin. Biol. Ther. 2003, 3:843-853.
31. Mourez M. Anthrax toxins. Rev. Physiol. Biochem. Pharmacol. 2004, 152:135-164.
32. Kolsto A.B., Tourasse N.J., Okstad O.A. What sets Bacillus anthracis apart from other Bacillus species?. Annu. Rev. Microbiol. 2009, 63:451-476.
33. Van Ert M.N., Easterday W.R., Huynh L.Y., Okinaka R.T., Hugh-Jones M.E., Ravel J., Zanecki S.R., Pearson T., Simonson T.S., U'Ren J.M., Kachur S.M., Leadem-Dougherty R.R., Rhoton S.D., Zinser G., Farlow J., Coker P.R., Smith K.L., Wang B., Kenefic L.J., Fraser-Liggett C.M., Wagner D.M., Keim P. Global genetic population structure of Bacillus anthracis. PLoS One 2007, 2:e461.
34. Goossens P.L. Animal models of human anthrax: the quest for the Holy Grail. Mol. Aspects Med. 2009, 30:467-480.
35. Lincoln R.E., Walker J.S., Klein F., Rosenwald A.J., Jones W.I. Value of field data for extrapolation in anthrax. Fed. Proc. 1967, 26:1558-1562.
36. Ross J.M. The pathogenesis of anthrax following the administration of spores by the respiratory route. J. Pathol. Bacteriol. 1957, 73:485-494.
37. Abramova F.A., Grinberg L.M., Yampolskaya O.V., Walker D.H. Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:2291-2294.
38. Grinberg L.M., Abramova F.A., Yampolskaya O.V., Walker D.H., Smith J.H. Quantitative pathology of inhalational anthrax I: quantitative microscopic findings. Mod. Pathol. 2001, 14:482-495.
39. Albrink W.S., Brooks S.M., Biron R.E., Kopel M. Human inhalation anthrax. A report of three fatal cases. Am. J. Pathol. 1960, 36:457-471.
40. Holty J.E., Bravata D.M., Liu H., Olshen R.A., McDonald K.M., Owens D.K. Systematic review: a century of inhalational anthrax cases from 1900 to 2005. Ann. Intern. Med. 2006, 144:270-280.
41. Holty J.E., Kim R.Y., Bravata D.M. Anthrax: a systematic review of atypical presentations. Ann. Emerg. Med. 2006, 48:200-211.
42. Jernigan J.A., Stephens D.S., Ashford D.A., Omenaca C., Topiel M.S., Galbraith M., Tapper M., Fisk T.L., Zaki S., Popovic T., Meyer R.F., Quinn C.P., Harper S.A., Fridkin S.K., Sejvar J.J., Shepard C.W., McConnell M., Guarner J., Shieh W.J., Malecki J.M., Gerberding J.L., Hughes J.M., Perkins B.A. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg. Infect. Dis. 2001, 7:933-944.
43. Ross J.M. On the histopathology of experimental anthrax in the guinea-pig. Br. J. Exp. Pathol. 1955, 36:336-339.
44. Smith H., Keppie J. Observations on experimental anthrax; demonstration of a specific lethal factor produced in vivo by Bacillus anthracis. Nature 1954, 173:869-870.
45. Zaucha G.M., Pitt L.M., Estep J., Ivins B.E., Friedlander A.M. The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation. Arch. Pathol. Lab. Med. 1998, 122:982-992.
46. Beall F.A., Dalldorf F.G. The pathogenesis of the lethal effect of anthrax toxin in the rat. J. Infect. Dis. 1966, 116:377-389.
47. Eckert N.J., Bonventre P.F. Invivo effects of Bacillus anthracis culture filtrates. J. Infect. Dis. 1963, 112:226-232.
48. Firoved A.M., Miller G.F., Moayeri M., Kakkar R., Shen Y., Wiggins J.F., McNally E.M., Tang W.J., Leppla S.H. Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice. Am. J. Pathol. 2005, 167:1309-1320.
49. Firoved A.M., Moayeri M., Wiggins J.F., Shen Y., Tang W.J., Leppla S.H. Anthrax edema toxin sensitizes DBA/2J mice to lethal toxin. Infect. Immun. 2007, 75:2120-2125.
50. Moayeri M., Haines D., Young H.A., Leppla S.H. Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice. J. Clin. Invest. 2003, 112:670-682.
51. Gozes Y., Moayeri M., Wiggins J.F., Leppla S.H. Anthrax lethal toxin induces ketotifen-sensitive intradermal vascular leakage in certain inbred mice. Infect. Immun. 2006, 74:1266-1272.
52. Cui X., Li Y., Li X., Laird M.W., Subramanian M., Moayeri M., Leppla S.H., Fitz Y., Su J., Sherer K., Eichacker P.Q. Bacillus anthracis edema and lethal toxin have different hemodynamic effects but function together to worsen shock and outcome in a rat model. J. Infect. Dis. 2007, 195:572-580.
53. Cui X., Moayeri M., Li Y., Li X., Haley M., Fitz Y., Correa-Araujo R., Banks S.M., Leppla S.H., Eichacker P.Q. Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not inflammatory cytokine or nitric oxide release in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 286:R699-R709.
54. Culley N.C., Pinson D.M., Chakrabarty A., Mayo M.S., Levine S.M. Pathophysiological manifestations in mice exposed to anthrax lethal toxin. Infect. Immun. 2005, 73:7006-7010.
55. Moayeri M., Crown D., Dorward D.W., Gardner D., Ward J.M., Li Y., Cui X., Eichacker P., Leppla S.H. The heart is an early target of anthrax lethal toxin in mice: a protective role for neuronal nitric oxide synthase (nNOS). PLoS Pathog. 2009, 5:e1000456.
56. Tessier J., Green C., Padgett D., Zhao W., Schwartz L., Hughes M., Hewlett E. Contributions of histamine, prostanoids, and neurokinins to edema elicited by edema toxin from Bacillus anthracis. Infect. Immun. 2007, 75:1895-1903.
57. van Sorge N.M., Ebrahimi C.M., McGillivray S.M., Quach D., Sabet M., Guiney D.G., Doran K.S. Anthrax toxins inhibit neutrophil signaling pathways in brain endothelium and contribute to the pathogenesis of meningitis. PLoS One 2008, 3:e2964.
58. Watson L.E., Kuo S.R., Katki K., Dang T., Park S.K., Dostal D.E., Tang W.J., Leppla S.H., Frankel A.E. Anthrax toxins induce shock in rats by depressed cardiac ventricular function. PLoS One 2007, 2:e466.
59. Watson L.E., Mock J., Lal H., Lu G., Bourdeau R.W., Tang W.J., Leppla S.H., Dostal D.E., Frankel A.E. Lethal and edema toxins of anthrax induce distinct hemodynamic dysfunction. Front. Biosci. 2007, 12:4670-4675.
60. Fritz D.L., Jaax N.K., Lawrence W.B., Davis K.J., Pitt M.L., Ezzell J.W., Friedlander A.M. Pathology of experimental inhalation anthrax in the rhesus monkey. Lab. Invest. 1995, 73:691-702.
61. Henderson D.W., Peacock S., Belton F.C. Observations on the prophylaxis of experimental pulmonary anthrax in the monkey. J. Hyg. (Lond.) 1956, 54:28-36.
62. Klein F., Lincoln R.E., Dobbs J.P., Mahlandt B.G., Remmele N.S., Walker J.S. Neurological and physiological responses of the primate to anthrax infection. J. Infect. Dis. 1968, 118:97-103.
63. Stearns-Kurosawa D.J., Lupu F., Taylor F.B., Kinasewitz G., Kurosawa S. Sepsis and pathophysiology of anthrax in a nonhuman primate model. Am. J. Pathol. 2006, 169:433-444.
64. Vasconcelos D., Barnewall R., Babin M., Hunt R., Estep J., Nielsen C., Carnes R., Carney J. Pathology of inhalation anthrax in cynomolgus monkeys (Macaca fascicularis). Lab. Invest. 2003, 83:1201-1209.
65. Albrink W.S., Goodlow R.J. Experimental inhalation anthrax in the chimpanzee. Am. J. Pathol. 1959, 35:1055-1065.
66. Klein F., Hodges D.R., Mahlandt B.G., Jones W.I., Haines B.W., Lincoln R.E. Anthrax toxin: causative agent in the death of rhesus monkeys. Science 1962, 138:1331-1333.
67. Pezard C., Berche P., Mock M. Contribution of individual toxin components to virulence of Bacillus anthracis. Infect. Immun. 1991, 59:3472-3477.
68. Paccani S.R., Tonello F., Ghittoni R., Natale M., Muraro L., D'Elios M.M., Tang W.J., Montecucco C., Baldari C.T. Anthrax toxins suppress T lymphocyte activation by disrupting antigen receptor signaling. J. Exp. Med. 2005, 201:325-331.
69. Drysdale M., Olson G., Koehler T.M., Lipscomb M.F., Lyons C.R. Murine innate immune response to virulent toxigenic and nontoxigenic Bacillus anthracis strains. Infect. Immun. 2007, 75:1757-1764.
70. Dumetz F., Jouvion G., Khun H., Glomski I.J., Corre J.P., Rougeaux C., Tang W.J., Mock M., Huerre M., Goossens P.L. Noninvasive imaging technologies reveal edema toxin as a key virulence factor in anthrax. Am. J. Pathol. 2011, 178:2523-2535.
71. Guichard A., McGillivray S.M., Cruz-Moreno B., van Sorge N.M., Nizet V., Bier E. Anthrax toxins cooperatively inhibit endocytic recycling by the Rab11/Sec15 exocyst. Nature 2010, 467:854-858.
72. Liu S., Miller-Randolph S., Crown D., Moayeri M., Sastalla I., Okugawa S., Leppla S.H. Anthrax toxin targeting of myeloid cells through the CMG2 receptor is essential for establishment of Bacillus anthracis infections in mice. Cell Host Microbe 2010, 8:455-462.
73. Liu S., Crown D., Miller-Randolph S., Moayeri M., Wang H., Hu H., Morley T., Leppla S.H. Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin invivo. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:12424-12429.
74. Banks D.J., Ward S.C., Bradley K.A. New insights into the functions of anthrax toxin. Expert Rev. Mol. Med. 2006, 8:1-18.
75. Frankel A.E., Kuo S.R., Dostal D., Watson L., Duesbery N.S., Cheng C.P., Cheng H.J., Leppla S.H. Pathophysiology of anthrax. Front. Biosci. 2009, 14:4516-4524.
76. Moayeri M., Leppla S.H. Cellular and systemic effects of anthrax lethal toxin and edema toxin. Mol. Aspects Med. 2009, 30:439-455.
77. Tournier J.N., Rossi Paccani S., Quesnel-Hellmann A., Baldari C.T. Anthrax toxins: a weapon to systematically dismantle the host immune defenses. Mol. Aspects Med. 2009, 30:456-466.
78. Glomski I.J., Piris-Gimenez A., Huerre M., Mock M., Goossens P.L. Primary involvement of pharynx and peyer's patch in inhalational and intestinal anthrax. PLoS Pathog 2007, 3:e76.
79. Boyden E.D., Dietrich W.F. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat. Genet. 2006, 38:240-244.
80. Pellizzari R., Guidi-Rontani C., Vitale G., Mock M., Montecucco C. Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha. FEBS Lett. 1999, 462:199-204.
81. Klein F., Haines B.W., Mahlandt B.G., Dearmon I.A., Lincoln R.E. Dual nature of resistance mechanisms as revealed by studies of anthrax septicemia. J. Bacteriol. 1963, 85:1032-1038.
82. Welkos S.L., Keener T.J., Gibbs P.H. Differences in susceptibility of inbred mice to Bacillus anthracis. Infect. Immun. 1986, 51:795-800.
83. Moayeri M., Crown D., Newman Z.L., Okugawa S., Eckhaus M., Cataisson C., Liu S., Sastalla I., Leppla S.H. Inflammasome sensor Nlrp1b-dependent resistance to anthrax is mediated by caspase-1, IL-1 signaling and neutrophil recruitment. PLoS Pathog. 2010, 6:e1001222.
84. Terra J.K., Cote C.K., France B., Jenkins A.L., Bozue J.A., Welkos S.L., LeVine S.M., Bradley K.A. Cutting edge: resistance to Bacillus anthracis infection mediated by a lethal toxin sensitive allele of Nalp1b/Nlrp1b. J. Immunol. 2010, 184:17-20.
85. Newman Z.L., Printz M.P., Liu S., Crown D., Breen L., Miller-Randolph S., Flodman P., Leppla S.H., Moayeri M. Susceptibility to anthrax lethal toxin-induced rat death is controlled by a single chromosome 10 locus that includes rNlrp1. PLoS Pathog. 2010, 6:e1000906.
86. Ribot W.J., Panchal R.G., Brittingham K.C., Ruthel G., Kenny T.A., Lane D., Curry B., Hoover T.A., Friedlander A.M., Bavari S. Anthrax lethal toxin impairs innate immune functions of alveolar macrophages and facilitates Bacillus anthracis survival. Infect. Immun. 2006, 74:5029-5034.
87. Kim C., Wilcox-Adelman S., Sano Y., Tang W.J., Collier R.J., Park J.M. Antiinflammatory cAMP signaling and cell migration genes co-opted by the anthrax bacillus. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:6150-6155.
88. Szarowicz S.E., During R.L., Li W., Quinn C.P., Tang W.J., Southwick F.S. Bacillus anthracis edema toxin impairs neutrophil actin-based motility. Infect. Immun. 2009, 77:2455-2464.
89. Hong J., Doebele R.C., Lingen M.W., Quilliam L.A., Tang W.J., Rosner M.R. Anthrax edema toxin inhibits endothelial cell chemotaxis via Epac and Rap1. J. Biol. Chem. 2007, 282:19781-19787.
90. Paccani S.R., Tonello F., Patrussi L., Capitani N., Simonato M., Montecucco C., Baldari C.T. Anthrax toxins inhibit immune cell chemotaxis by perturbing chemokine receptor signalling. Cell. Microbiol. 2007, 9:924-929.
91. Agrawal A., Lingappa J., Leppla S.H., Agrawal S., Jabbar A., Quinn C., Pulendran B. Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin. Nature 2003, 424:329-334.
92. Chou P.J., Newton C.A., Perkins I., Friedman H., Klein T.W. Suppression of dendritic cell activation by anthrax lethal toxin and edema toxin depends on multiple factors including cell source, stimulus used, and function tested. DNA Cell Biol. 2008, 27:637-648.
93. Comer J.E., Chopra A.K., Peterson J.W., Konig R. Direct inhibition of T-lymphocyte activation by anthrax toxins invivo. Infect. Immun. 2005, 73:8275-8281.
94. Tournier J.N., Quesnel-Hellmann A., Mathieu J., Montecucco C., Tang W.J., Mock M., Vidal D.R., Goossens P.L. Anthrax edema toxin cooperates with lethal toxin to impair cytokine secretion during infection of dendritic cells. J. Immunol. 2005, 174:4934-4941.
95. Park J.M., Greten F.R., Wong A., Westrick R.J., Arthur J.S., Otsu K., Hoffmann A., Montminy M., Karin M. Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis - CREB and NF-kappaB as key regulators. Immunity 2005, 23:319-329.
96. Goldman D.L., Casadevall A. Anthrax-associated shock. Front. Biosci. 2008, 13:4009-4014.
97. Golden H.B., Watson L.E., Lal H., Verma S.K., Foster D.M., Kuo S.R., Sharma A., Frankel A., Dostal D.E. Anthrax toxin: pathologic effects on the cardiovascular system. Front. Biosci. 2009, 14:2335-2357.
98. Sherer K., Li Y., Cui X., Eichacker P.Q. Lethal and edema toxins in the pathogenesis of Bacillus anthracis septic shock: implications for therapy. Am. J. Respir. Crit. Care Med. 2007, 175:211-221.
99. Li Y., Sherer K., Cui X., Eichacker P.Q. New insights into the pathogenesis and treatment of anthrax toxin-induced shock. Expert Opin. Biol. Ther. 2007, 7:843-854.
100. Ali S.R., Timmer A.M., Bilgrami S., Park E.J., Eckmann L., Nizet V., Karin M. Anthrax toxin induces macrophage death by p38 MAPK inhibition but leads to inflammasome activation via ATP leakage. Immunity 2011, 35:34-44.
101. Kalns J., Scruggs J., Millenbaugh N., Vivekananda J., Shealy D., Eggers J., Kiel J. TNF receptor 1, IL-1 receptor, and iNOS genetic knockout mice are not protected from anthrax infection. Biochem. Biophys. Res. Commun. 2002, 292:41-44.
102. Moayeri M., Webster J.I., Wiggins J.F., Leppla S.H., Sternberg E.M. Endocrine perturbation increases susceptibility of mice to anthrax lethal toxin. Infect. Immun. 2005, 73:4238-4244.
103. Mina B., Dym J.P., Kuepper F., Tso R., Arrastia C., Kaplounova I., Faraj H., Kwapniewski A., Krol C.M., Grosser M., Glick J., Fochios S., Remolina A., Vasovic L., Moses J., Robin T., DeVita M., Tapper M.L. Fatal inhalational anthrax with unknown source of exposure in a 61-year-old woman in New York City. JAMA 2002, 287:858-862.
104. Sherer K., Li Y., Cui X., Li X., Subramanian M., Laird M.W., Moayeri M., Leppla S.H., Fitz Y., Su J., Eichacker P.Q. Fluid support worsens outcome and negates the benefit of protective antigen-directed monoclonal antibody in a lethal toxin-infused rat Bacillus anthracis shock model. Crit. Care Med. 2007, 35:1560-1567.
105. Warfel J.M., Steele A.D., D'Agnillo F. Anthrax lethal toxin induces endothelial barrier dysfunction. Am. J. Pathol. 2005, 166:1871-1881.
106. Bolcome R.E., Sullivan S.E., Zeller R., Barker A.P., Collier R.J., Chan J. Anthrax lethal toxin induces cell death-independent permeability in zebrafish vasculature. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:2439-2444.
107. Kirby J.E. Anthrax lethal toxin induces human endothelial cell apoptosis. Infect. Immun. 2004, 72:430-439.
108. Paddle B.M., Wong V.K., Muller B.D. The cytotoxic effect of anthrax lethal toxin on human lung cells invitro and the protective action of bovine antibodies to PA and LF. J. Appl. Toxicol. 2006, 26:162-168.
109. Hicks C.W., Li Y., Okugawa S., Solomon S.B., Moayeri M., Leppla S.H., Mohanty A., Subramanian G.M., Mignone T.S., Fitz Y., Cui X., Eichacker P.Q. Anthrax edema toxin has cAMP-mediated stimulatory effects and high-dose lethal toxin has depressant effects in an isolated perfused rat heart model. Am. J. Physiol. Heart Circ. Physiol. 2011, 300:H1108-H1118.
110. Kuo S.R., Willingham M.C., Bour S.H., Andreas E.A., Park S.K., Jackson C., Duesbery N.S., Leppla S.H., Tang W.J., Frankel A.E. Anthrax toxin-induced shock in rats is associated with pulmonary edema and hemorrhage. Microb. Pathog. 2008, 44:467-472.
111. Sweeney D.A., Cui X., Solomon S.B., Vitberg D.A., Migone T.S., Scher D., Danner R.L., Natanson C., Subramanian G.M., Eichacker P.Q. Anthrax lethal and edema toxins produce different patterns of cardiovascular and renal dysfunction and synergistically decrease survival in canines. J. Infect. Dis. 2010, 202:1885-1896.
112. Bolcome R.E., Chan J. Constitutive MEK1 activation rescues anthrax lethal toxin-induced vascular effects invivo. Infect. Immun. 2010, 78:5043-5053.
113. Kandadi M.R., Hua Y., Ma H., Li Q., Kuo S.R., Frankel A.E., Ren J. Anthrax lethal toxin suppresses murine cardiomyocyte contractile function and intracellular Ca2+ handling via a NADPH oxidase-dependent mechanism. PLoS One 2010, 5:e13335.
114. Vick J.A., Lincoln R.E., Klein F., Mahlandt B.G., Walker J.S., Fish D.C. Neurological and physiological responses of the primate to anthrax toxin. J. Infect. Dis. 1968, 118:85-96.
115. Fish D.C., Klein F., Lincoln R.E., Walker J.S., Dobbs J.P. Pathophysiological changes in the rat associated with anthrax toxin. J. Infect. Dis. 1968, 118:114-124.
116. Levy H., Weiss S., Altboum Z., Schlomovitz J., Rothschild N., Blachinsky E., Kobiler D. Lethal factor is not required for Bacillus anthracis virulence in guinea pigs and rabbits. Microb. Pathog. 2011.
117. Goldstein B., Macara I.G. The PAR proteins: fundamental players in animal cell polarization. Dev. Cell 2007, 13:609-622.
118. Knust E., Bossinger O. Composition and formation of intercellular junctions in epithelial cells. Science 2002, 298:1955-1959.
119. Yamanaka T., Ohno S. Role of Lgl/Dlg/Scribble in the regulation of epithelial junction, polarity and growth. Front. Biosci. 2008, 13:6693-6707.
120. Niessen C.M., Gottardi C.J. Molecular components of the adherens junction. Biochim. Biophys. Acta 2008, 1778:562-571.
121. Komarova Y., Malik A.B. Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annu. Rev. Physiol. 2010, 72:463-493.
122. Banerjee S., Sousa A.D., Bhat M.A. Organization and function of septate junctions: an evolutionary perspective. Cell Biochem. Biophys. 2006, 46:65-77.
123. Dejana E., Orsenigo F., Lampugnani M.G. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J. Cell Sci. 2008, 121:2115-2122.
124. Dejana E., Tournier-Lasserve E., Weinstein B.M. The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev. Cell 2009, 16:209-221.
125. He B., Guo W. The exocyst complex in polarized exocytosis. Curr. Opin. Cell Biol. 2009, 21:537-542.
126. Munson M., Novick P. The exocyst defrocked, a framework of rods revealed. Nat. Struct. Mol. Biol. 2006, 13:577-581.
127. Bendezu F.O., Martin S.G. Actin cables and the exocyst form two independent morphogenesis pathways in the fission yeast. Mol. Biol. Cell 2010, 22:44-53.
128. Weis S.M., Cheresh D.A. Pathophysiological consequences of VEGF-induced vascular permeability. Nature 2005, 437:497-504.
129. Bigas A., Robert-Moreno A., Espinosa L. The Notch pathway in the developing hematopoietic system. Int. J. Dev. Biol. 2010, 54:1175-1188.
130. Kume T. Novel insights into the differential functions of Notch ligands in vascular formation. J. Angiogenes Res. 2009, 1:8.
131. Eilken H.M., Adams R.H. Dynamics of endothelial cell behavior in sprouting angiogenesis. Curr. Opin. Cell Biol. 2010, 22:617-625.
132. Dufraine J., Funahashi Y., Kitajewski J. Notch signaling regulates tumor angiogenesis by diverse mechanisms. Oncogene 2008, 27:5132-5137.
133. Capaldo C.T., Macara I.G. Depletion of E-cadherin disrupts establishment but not maintenance of cell junctions in Madin-Darby canine kidney epithelial cells. Mol. Biol. Cell 2007, 18:189-200.
134. Taddei A., Giampietro C., Conti A., Orsenigo F., Breviario F., Pirazzoli V., Potente M., Daly C., Dimmeler S., Dejana E. Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat. Cell Biol. 2008, 10:923-934.
135. Depeille P.E., Ding Y., Bromberg-White J.L., Duesbery N.S. MKK signaling and vascularization. Oncogene 2007, 26:1290-1296.
136. E. Bier, A. Guichard, Deconstructing host-pathogen interactions in Drosophila, Dis. Model Mech. 4, in press, doi:10.1242/dmm.000406.
137. Brand A.H., Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 1993, 118:401-415.
138. Guichard A., Park J.M., Cruz-Moreno B., Karin M., Bier E. Anthrax lethal factor and edema factor act on conserved targets in Drosophila. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:3244-3249.
139. Jafar-Nejad H., Andrews H.K., Acar M., Bayat V., Wirtz-Peitz F., Mehta S.Q., Knoblich J.A., Bellen H.J. Sec15, a component of the exocyst, promotes notch signaling during the asymmetric division of Drosophila sensory organ precursors. Dev. Cell 2005, 9:351-363.
140. Langevin J., Morgan M.J., Sibarita J.B., Aresta S., Murthy M., Schwarz T., Camonis J., Bellaiche Y. Drosophila exocyst components Sec5, Sec6, and Sec15 regulate DE-Cadherin trafficking from recycling endosomes to the plasma membrane. Dev. Cell 2005, 9:365-376.
141. Ebrahimi C.M., Sheen T.R., Renken C.W., Gottlieb R.A., Doran K.S. Contribution of lethal toxin and edema toxin to the pathogenesis of anthrax meningitis. Infect. Immun. 2011, 79:2510-2518.
142. Rosse C., Formstecher E., Boeckeler K., Zhao Y., Kremerskothen J., White M.D., Camonis J.H., Parker P.J. An aPKC-exocyst complex controls paxillin phosphorylation and migration through localised JNK1 activation. PLoS Biol. 2009, 7:e1000235.
143. Balakireva M., Rosse C., Langevin J., Chien Y.C., Gho M., Gonzy-Treboul G., Voegeling-Lemaire S., Aresta S., Lepesant J.A., Bellaiche Y., White M., Camonis J. The Ral/exocyst effector complex counters c-Jun N-terminal kinase-dependent apoptosis in Drosophila melanogaster. Mol. Cell. Biol. 2006, 26:8953-8963.
144. Park K.M., Fogelgren B., Zuo X., Kim J., Chung D.C., Lipschutz J.H. Exocyst Sec10 protects epithelial barrier integrity and enhances recovery following oxidative stress, by activation of the MAPK pathway. Am. J. Physiol. Renal Physiol. 2010, 298:F818-F826.
145. Nada S., Hondo A., Kasai A., Koike M., Saito K., Uchiyama Y., Okada M. The novel lipid raft adaptor p18 controls endosome dynamics by anchoring the MEK-ERK pathway to late endosomes. EMBO J. 2009, 28:477-489.
146. Horgan C.P., McCaffrey M.W. The dynamic Rab11-FIPs. Biochem. Soc. Trans. 2009, 37:1032-1036.
147. Goehring A.S., Pedroja B.S., Hinke S.A., Langeberg L.K., Scott J.D. MyRIP anchors protein kinase A to the exocyst complex. J. Biol. Chem. 2007, 282:33155-33167.
148. Qiao J., Mei F.C., Popov V.L., Vergara L.A., Cheng X. Cell cycle-dependent subcellular localization of exchange factor directly activated by cAMP. J. Biol. Chem. 2002, 277:26581-26586.
149. Knox A.L., Brown N.H. Rap1 GTPase regulation of adherens junction positioning and cell adhesion. Science 2002, 295:1285-1288.
150. Sakurai A., Fukuhara S., Yamagishi A., Sako K., Kamioka Y., Masuda M., Nakaoka Y., Mochizuki N. MAGI-1 is required for Rap1 activation upon cell-cell contact and for enhancement of vascular endothelial cadherin-mediated cell adhesion. Mol. Biol. Cell 2006, 17:966-976.
151. Boettner B., Van Aelst L. Control of cell adhesion dynamics by Rap1 signaling. Curr. Opin. Cell Biol. 2009, 21:684-693.
152. Frische E.W., Zwartkruis F.J. Rap1, a mercenary among the Ras-like GTPases. Dev. Biol. 2010, 340:1-9.
153. Boettner B., Harjes P., Ishimaru S., Heke M., Fan H.Q., Qin Y., Van Aelst L., Gaul U. The AF-6 homolog canoe acts as a Rap1 effector during dorsal closure of the Drosophila embryo. Genetics 2003, 165:159-169.
154. Hoshino T., Sakisaka T., Baba T., Yamada T., Kimura T., Takai Y. Regulation of E-cadherin endocytosis by nectin through afadin, Rap1, and p120ctn. J. Biol. Chem. 2005, 280:24095-24103.
155. Glading A., Han J., Stockton R.A., Ginsberg M.H. KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell-cell junctions. J. Cell Biol. 2007, 179:247-254.
156. Adamson R.H., Ly J.C., Sarai R.K., Lenz J.F., Altangerel A., Drenckhahn D., Curry F.E. Epac/Rap1 pathway regulates microvascular hyperpermeability induced by PAF in rat mesentery. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H1188-H1196.
157. Fukuhara S., Sakurai A., Sano H., Yamagishi A., Somekawa S., Takakura N., Saito Y., Kangawa K., Mochizuki N. Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol. Cell. Biol. 2005, 25:136-146.
158. Kooistra M.R., Corada M., Dejana E., Bos J.L. Epac1 regulates integrity of endothelial cell junctions through VE-cadherin. FEBS Lett. 2005, 579:4966-4972.
159. Vandenbroucke E., Mehta D., Minshall R., Malik A.B. Regulation of endothelial junctional permeability. Ann. N. Y. Acad. Sci. 2008, 1123:134-145.
160. Ahuja N., Kumar P., Bhatnagar R. The adenylate cyclase toxins. Crit. Rev. Microbiol. 2004, 30:187-196.
161. Paccani S.R., Benagiano M., Capitani N., Zornetta I., Ladant D., Montecucco C., D'Elios M.M., Baldari C.T. The adenylate cyclase toxins of Bacillus anthracis and Bordetella pertussis promote Th2 cell development by shaping T cell antigen receptor signaling. PLoS Pathog. 2009, 5:e1000325.
162. Puhar A., Dal Molin F., Horvath S., Ladant D., Montecucco C. Anthrax edema toxin modulates PKA- and CREB-dependent signaling in two phases. PLoS One 2008, 3:e3564.
163. Sayner S.L., Frank D.W., King J., Chen H., VandeWaa J., Stevens T. Paradoxical cAMP-induced lung endothelial hyperpermeability revealed by Pseudomonas aeruginosa ExoY. Circ. Res. 2004, 95:196-203.
164. Blum M.S., Toninelli E., Anderson J.M., Balda M.S., Zhou J., O'Donnell L., Pardi R., Bender J.R. Cytoskeletal rearrangement mediates human microvascular endothelial tight junction modulation by cytokines. Am. J. Physiol. 1997, 273:H286-H294.
165. Qiao R.L., Bhattacharya J. Segmental barrier properties of the pulmonary microvascular bed. J. Appl. Physiol. 1991, 71:2152-2159.
166. Schneeberger E.E. Segmental differentiation of endothelial intercellular junctions in intra-acinar arteries and veins of the rat lung. Circ. Res. 1981, 49:1102-1111.
167. Stevens T., Creighton J., Thompson W.J. Control of cAMP in lung endothelial cell phenotypes. Implications for control of barrier function. Am. J. Physiol. 1999, 277:L119-L126.
168. Beauregard K.E., Wimer-Mackin S., Collier R.J., Lencer W.I. Anthrax toxin entry into polarized epithelial cells. Infect. Immun. 1999, 67:3026-3030.
169. Winkler E.A., Bell R.D., Zlokovic B.V. Lack of Smad or Notch leads to a fatal game of brain pericyte hopscotch. Dev. Cell 2011, 20:279-280.
170. Greenberg J.I., Shields D.J., Barillas S.G., Acevedo L.M., Murphy E., Huang J., Scheppke L., Stockmann C., Johnson R.S., Angle N., Cheresh D.A. A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature 2008, 456:809-813.
171. Cherry S. Genomic RNAi screening in Drosophila S2 cells: what have we learned about host-pathogen interactions?. Curr. Opin. Microbiol. 2008, 11:262-270.
172. Piris-Gimenez A., Corre J.P., Jouvion G., Candela T., Khun H., Goossens P.L. Encapsulated Bacillus anthracis interacts closely with liver endothelium. J. Infect. Dis. 2009, 200:1381-1389.
173. Ezzell J.W., Abshire T.G., Panchal R., Chabot D., Bavari S., Leffel E.K., Purcell B., Friedlander A.M., Ribot W.J. Association of Bacillus anthracis capsule with lethal toxin during experimental infection. Infect. Immun. 2009, 77:749-755.
174. Kern J., Schneewind O. BslA, the S-layer adhesin of B. anthracis, is a virulence factor for anthrax pathogenesis. Mol. Microbiol. 2010, 75:324-332.
175. Ebrahimi C.M., Kern J.W., Sheen T.R., Ebrahimi-Fardooee M.A., van Sorge N.M., Schneewind O., Doran K.S. Penetration of the blood-brain barrier by Bacillus anthracis requires the pXO1-encoded BslA protein. J. Bacteriol. 2009, 191:7165-7173.
176. Huffman D.L., Abrami L., Sasik R., Corbeil J., van der Goot F.G., Aroian R.V. Mitogen-activated protein kinase pathways defend against bacterial pore-forming toxins. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:10995-11000.
177. Park J.M., Ng V.H., Maeda S., Rest R.F., Karin M. Anthrolysin O and other gram-positive cytolysins are toll-like receptor 4 agonists. J. Exp. Med. 2004, 200:1647-1655.
178. Popova T.G., Millis B., Bradburne C., Nazarenko S., Bailey C., Chandhoke V., Popov S.G. Acceleration of epithelial cell syndecan-1 shedding by anthrax hemolytic virulence factors. BMC Microbiol. 2006, 6:8.
179. Bishop B.L., Lodolce J.P., Kolodziej L.E., Boone D.L., Tang W.J. The role of anthrolysin O in gut epithelial barrier disruption during Bacillus anthracis infection. Biochem. Biophys. Res. Commun. 2010, 394:254-259.
180. Los F.C., Kao C.Y., Smitham J., McDonald K.L., Ha C., Peixoto C.A., Aroian R.V. RAB-5- and RAB-11-dependent vesicle-trafficking pathways are required for plasma membrane repair after attack by bacterial pore-forming toxin. Cell Host Microbe 2011, 9:147-157.
181. Chitlaru T., Shafferman A. Proteomic studies of Bacillus anthracis. Future Microbiol. 2009, 4:983-998.
182. Chung M.C., Popova T.G., Millis B.A., Mukherjee D.V., Zhou W., Liotta L.A., Petricoin E.F., Chandhoke V., Bailey C., Popov S.G. Secreted neutral metalloproteases of Bacillus anthracis as candidate pathogenic factors. J. Biol. Chem. 2006, 281:31408-31418.
183. Mukherjee D.V., Tonry J.H., Kim K.S., Ramarao N., Popova T.G., Bailey C., Popov S., Chung M.C. Bacillus anthracis protease InhA increases blood-brain barrier permeability and contributes to cerebral hemorrhages. PLoS One 2011, 6:e17921.
184. Kastrup C.J., Boedicker J.Q., Pomerantsev A.P., Moayeri M., Bian Y., Pompano R.R., Kline T.R., Sylvestre P., Shen F., Leppla S.H., Tang W.J., Ismagilov R.F. Spatial localization of bacteria controls coagulation of human blood by 'quorum acting'. Nat. Chem. Biol. 2008, 4:742-750.
185. Saile E., Koehler T.M. Bacillus anthracis multiplication, persistence, and genetic exchange in the rhizosphere of grass plants. Appl. Environ. Microbiol. 2006, 72:3168-3174.
186. Kenefic L.J., Pearson T., Okinaka R.T., Schupp J.M., Wagner D.M., Hoffmaster A.R., Trim C.B., Chung W.K., Beaudry J.A., Jiang L., Gajer P., Foster J.T., Mead J.I., Ravel J., Keim P. Pre-Columbian origins for North American anthrax. PLoS One 2009, 4:e4813.
187. Mignot T., Mock M., Robichon D., Landier A., Lereclus D., Fouet A. The incompatibility between the PlcR- and AtxA-controlled regulons may have selected a nonsense mutation in Bacillus anthracis. Mol. Microbiol. 2001, 42:1189-1198.
188. Sastalla I., Maltese L.M., Pomerantseva O.M., Pomerantsev A.P., Keane-Myers A., Leppla S.H. Activation of the latent PlcR regulon in Bacillus anthracis. Microbiology 2010, 156:2982-2993.
189. Fieldhouse R.J., Turgeon Z., White D., Merrill A.R. Cholera- and anthrax-like toxins are among several new ADP-ribosyltransferases. PLoS Comput. Biol. 2010, 6:e1001029.
190. Hoffmaster A.R., Hill K.K., Gee J.E., Marston C.K., De B.K., Popovic T., Sue D., Wilkins P.P., Avashia S.B., Drumgoole R., Helma C.H., Ticknor L.O., Okinaka R.T., Jackson P.J. Characterization of Bacillus cereus isolates associated with fatal pneumonias: strains are closely related to Bacillus anthracis and harbor B. anthracis virulence genes. J. Clin. Microbiol. 2006, 44:3352-3360.